Cerillion plc (LON:CER) CEO Louis Hall joins DirectorsTalk Interviews to discuss its interim results for the six months ended 31 March 2023. Louis talks us through the key numbers, if there
Anglo Asian Mining (LON:AAZ) is the topic of conversation when Paul Mylchreest, Analyst at Hardman & Co joins DirectorsTalk Interviews. Paul gives us an overview of Anglo Asian Mining, outlines for
XP Factory plc (LON:XPF) Chief Executive Officer Richard Harpham joins DirectorsTalk Interviews to discuss final results for the year ended 31 December 2022. Richard talks us through the result highlights, the
Ilika Plc (LON:IKA) CEO Graeme Purdy joins DirectorsTalk Interviews to discuss an update on trading, Stereax® manufacturing, and Goliath product development, as well as full year results for the year ended
Nuformix plc (LON:NFX), a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing, has announced its unaudited results for the twelve months ended 31 March 2023 following the
Accrol Group Holdings (LON:ACRL) CEO Gareth Jenkins joins DirectorsTalk Interviews to discuss a trading update ahead of its Final Results for the year ended 30 April 2023. Gareth explains what pleased
Hardide Plc (LON:HDD) CEO Phil Kirkham joins DirectorsTalk Interviews to discuss results for the six-month period ended 31 March 2023. In this interview CEO Phil Kirkham talks us through the financial
Surface Transforms plc (LON:SCE) is the topic of conversation when Mike Foster, Analyst at Hardman & Co joins DirectorsTalk Interviews. In this interview Mike explains where we are now despite several
Ilika plc (LON:IKA) CEO Graeme Purdy joins DirectorsTalk Interviews to discuss the first customer shipment of Stereax M300 stacked solid state batteries. In this interview Graeme reminds us of the target
Dekel Agri-vision (LON:DKL) Executive Director Lincoln Moore joins DirectorsTalk Interviews to discuss an April production update for its palm oil project in Côte d’Ivoire. In this interview Lincoln talks us through
© 2022 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
